tirzepatide trials vs. Semaglutide: What You Should Know Cardiovascular outcomes of semaglutide and
Description
2020;125 doi: 10.1016/j.peptides.2019.170174
"Obesity is a chronic treatable disease and we need to treat it as we treat other chronic, treatable diseases, with therapies that target disease mechanisms
In terms of side effects and tolerability, the advantage goes to Tirzepatide
For more on storage timelines, see how long semaglutide is good for
The STROBE reporting checklist was followed
Either way, a daily pill depends on consistent habit formation, which some individuals may find harder to sustain than a single weekly injection
